3141 Stock Overview
Operates a chain of drug stores with dispensing pharmacies in Japan.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 3141 from our risk checks.
Welcia Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,994.00 |
52 Week High | JP¥3,030.00 |
52 Week Low | JP¥1,816.00 |
Beta | -0.059 |
11 Month Change | -0.15% |
3 Month Change | 0.23% |
1 Year Change | -20.37% |
33 Year Change | -51.78% |
5 Year Change | -28.27% |
Change since IPO | 718.05% |
Recent News & Updates
Investors Could Be Concerned With Welcia Holdings' (TSE:3141) Returns On Capital
Sep 11Welcia Holdings (TSE:3141) Has Announced That It Will Be Increasing Its Dividend To ¥18.00
Aug 19Unpleasant Surprises Could Be In Store For Welcia Holdings Co., Ltd.'s (TSE:3141) Shares
Aug 13Welcia Holdings (TSE:3141) Is Increasing Its Dividend To ¥18.00
Jul 26Welcia Holdings (TSE:3141) Is Paying Out A Larger Dividend Than Last Year
Jul 12Recent updates
Investors Could Be Concerned With Welcia Holdings' (TSE:3141) Returns On Capital
Sep 11Welcia Holdings (TSE:3141) Has Announced That It Will Be Increasing Its Dividend To ¥18.00
Aug 19Unpleasant Surprises Could Be In Store For Welcia Holdings Co., Ltd.'s (TSE:3141) Shares
Aug 13Welcia Holdings (TSE:3141) Is Increasing Its Dividend To ¥18.00
Jul 26Welcia Holdings (TSE:3141) Is Paying Out A Larger Dividend Than Last Year
Jul 12Welcia Holdings (TSE:3141) Will Pay A Larger Dividend Than Last Year At ¥18.00
Jun 06Earnings Update: Welcia Holdings Co., Ltd. (TSE:3141) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Jun 02The Returns At Welcia Holdings (TSE:3141) Aren't Growing
May 22Some Investors May Be Willing To Look Past Welcia Holdings' (TSE:3141) Soft Earnings
Apr 15Analysts Have Made A Financial Statement On Welcia Holdings Co., Ltd.'s (TSE:3141) Annual Report
Apr 10Estimating The Intrinsic Value Of Welcia Holdings Co., Ltd. (TSE:3141)
Mar 30Welcia Holdings Co., Ltd. (TSE:3141) Investors Are Less Pessimistic Than Expected
Mar 14Shareholder Returns
3141 | JP Consumer Retailing | JP Market | |
---|---|---|---|
7D | 3.1% | 0.5% | 0.9% |
1Y | -20.4% | 9.5% | 8.7% |
Return vs Industry: 3141 underperformed the JP Consumer Retailing industry which returned 9.5% over the past year.
Return vs Market: 3141 underperformed the JP Market which returned 8.7% over the past year.
Price Volatility
3141 volatility | |
---|---|
3141 Average Weekly Movement | 4.2% |
Consumer Retailing Industry Average Movement | 4.9% |
Market Average Movement | 6.4% |
10% most volatile stocks in JP Market | 10.3% |
10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 3141 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3141's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1935 | 15,286 | Takamitsu Ikeno | www.welcia.co.jp |
Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores offer OTC products, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services, as well as housing services for elderly people.
Welcia Holdings Co., Ltd. Fundamentals Summary
3141 fundamental statistics | |
---|---|
Market cap | JP¥404.96b |
Earnings (TTM) | JP¥24.15b |
Revenue (TTM) | JP¥1.22t |
17.1x
P/E Ratio0.3x
P/S RatioIs 3141 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3141 income statement (TTM) | |
---|---|
Revenue | JP¥1.22t |
Cost of Revenue | JP¥852.50b |
Gross Profit | JP¥371.31b |
Other Expenses | JP¥347.16b |
Earnings | JP¥24.15b |
Last Reported Earnings
May 31, 2024
Next Earnings Date
Oct 07, 2024
Earnings per share (EPS) | 116.76 |
Gross Margin | 30.34% |
Net Profit Margin | 1.97% |
Debt/Equity Ratio | 16.7% |
How did 3141 perform over the long term?
See historical performance and comparison